Slide background

Your cells for your treatment: with its family of new generation therapies for hard & soft tissue reconstruction from autologous adipose stem cells
Novadip Biosciences offers a 3D solution that is impervious to immunisation and graft rejection, for better clinical outcomes.

A product family based on a single technology

An innovative family of cell-based regeneration therapies. Novadip Biosciences pioneers the growth of 3-dimensional biologics based on adipose-derived stem cells (ASC), to regenerate hard and soft tissues. ASCs offer sizable advantages in regeneration medicine. The fatty tissue has demonstrated a much higher proportion of stem cells compared to the bone marrow from which they were

Read More

Our Achievements

Since 2013, Novadip Biosciences has been developing breakthrough innovations in cell-based therapies for hard and soft tissue. While our first mission was to treat patients with bone defects and bone diseases, our adipose stem cell-based technology now offers potential for further applications, including skin regeneration.

Read More

Market Application

From advanced biopharmaceutical company Novadip Biosciences: a family of new generation, 3D therapies based on adipose stem cells, for hard and soft tissue reconstruction.   Market application for NVD-001: critical size bone defects with unmet medical needs. Critical size bone defects following trauma, infection, congenital deficiency or tumour resection remain a major healthcare issue because

Read More


Recent News

Novadip’s looking for a GMP Manufacturing Technician and a QC Scientist !

Please find job descriptions here.

Read More
Novadip is hiring a QA Assistant

You want to be part of a growing innovative biotech company ? Check out our vacant positions here.

Read More
Fast-growing biopharmaceutical company NOVADIP develops its product portfolio and moves to new premises offering on-site R&D and GMP facilities

Mont-Saint-Guibert, Belgium – June 21, 2016 – NOVADIP BIOSCIENCES, a biopharmaceutical spin-off company of Université catholique de Louvain, announces the

Read More